D L Du
Overview
Explore the profile of D L Du including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Zhao W, Jiao X, Du D, Liu Y
Eur J Gynaecol Oncol
. 2016 May;
37(2):204-10.
PMID: 27172746
Unlabelled: Summary Purpose: Ovarian cancer is the most deadly of all gynecologic malignancies, due in part to the diagnosis at an advanced stage caused by the deficiency of specific marks...
2.
Xia S, Xu C, Tang X, Wang W, Du D
Asian J Androl
. 2001 Jun;
3(2):131-4.
PMID: 11404798
Aim: To study the apoptotic rate (AR) and the androgen and estrogen milieu in the proximal and distal ductal systems of prostate, in order to help exploring the effects of...
3.
Volpe D, Du D, Grieshaber C, Murphy Jr M
Cancer Chemother Pharmacol
. 1994 Jan;
34(2):103-8.
PMID: 8194161
We studied the toxicity of a new experimental anticancer drug, cyclopentenyl cytosine (CPE-C), to human and murine hematopoietic progenitor cells in vitro. Due to CPE-C's in vivo myelotoxicity, it was...
4.
Volpe D, Du D, Verhoef V, Murphy Jr M
Pathobiology
. 1993 Jan;
61(2):77-82.
PMID: 8216829
Mycobacterial infection is a common complication of acquired immunodeficiency syndrome (AIDS) frequently requiring antimycobacterial medication. It was of interest to determine if one such agent, rifabutin, could be tolerated by...
5.
Volpe D, Du D, Zurlo M, Mongelli N, Murphy M
Invest New Drugs
. 1992 Nov;
10(4):255-61.
PMID: 1487398
FCE 24517, a derivative of distamycin A, exhibits an unusual antitumor profile in experimental models. As part of its preclinical development, we evaluated the in vitro myelotoxicity of FCE 24517...
6.
Du D, Volpe D, Grieshaber C, Murphy Jr M
Br J Haematol
. 1992 Apr;
80(4):437-45.
PMID: 1316140
The myelotoxicities of three antiretroviral agents, 3'-azido-3'-deoxythymidine (AZT), carbovir (CBV) and 2',3'-didehydro-2',3'-dideoxythymidine (d4T), were evaluated in vitro with normal human and murine haematopoietic progenitor cells. These studies demonstrated that continuous...
7.
Du D, Volpe D, Grieshaber C, Murphy Jr M
Int J Cell Cloning
. 1992 Mar;
10(2):87-93.
PMID: 1545153
Four nucleoside analogues, 2',3'-dideoxyinosine (ddI), 2',3'-dideoxyadenosine (ddA), 2',3'-dideoxycytosine (ddC) and 5-fluoro-2',3'-dideoxycytosine (5-F-ddC), were evaluated for their potential in vitro myelotoxic effects on normal murine hematopoietic progenitor cells. Myeloid granulocyte-macrophage colony-forming...
8.
Du D, Volpe D, Grieshaber C, Murphy Jr M
Invest New Drugs
. 1991 May;
9(2):149-57.
PMID: 1874599
The in vitro myelotoxic potentials of three investigational antitumor agents, Fostriecin, Hepsulfam and pyrazine diazohydroxide (PZDH), were evaluated utilizing clonogenic assays. Human and murine marrow cells were exposed to each...
9.
Volpe D, Du D, Pohl K, Campbell J, Murphy Jr M
Pathobiology
. 1991 Jan;
59(1):53-6.
PMID: 2043269
We describe the establishment of a convenient method of acquiring human bone marrow cells for use in microcapillary clonal assays. Femoral epiphyseal and diaphyseal bone fragments and femoral canal reamings...
10.
Du D, Volpe D, Grieshaber C, Murphy Jr M
Exp Hematol
. 1990 Aug;
18(7):832-6.
PMID: 2379548
Three nucleoside analogues, 2',3'-dideoxyadenosine (ddA), 2',3'-dideoxyinosine (ddI), and 2',3'-dideoxycytosine (ddC), were evaluated for their potential myelotoxic effects to normal human hematopoietic progenitor cells. The myeloid (granulocyte-monocyte colony-forming units, CFU-gm) and...